Skip to content

Clinical trials

Schizophrenia trials in Slovakia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Country / region: Slovakia Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20061
20074
20084
20093
20104
20115
20122
20132
20162
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.6
Sumitomo Pharma America, Inc.4
Eli Lilly and Company3
H. Lundbeck A/S3
Hoffmann-La Roche3
Janssen Research & Development, LLC3
Janssen-Cilag International NV3
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.3
Boehringer Ingelheim2
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia34
Psychotic Disorders3
Recurrence2
Adjustment Disorders1
Anxiety Disorders1
Bipolar Disorder1
Body Weight Changes1
Depressive Disorder1
Personality Disorders1

Trials

Showing 26 to 34 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.